Stephan Targan Selected Research

Therapeutics

1/2022	Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
1/2021	Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
1/2021	Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
12/2020	Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
1/2019	Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
7/2018	The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
1/2017	Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis.
11/2016	Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
3/2015	The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.
10/2012	Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Targan Research Topics

Disease

23	Crohn Disease (Crohn's Disease) 11/2023 - 02/2005
12	Ulcerative Colitis 01/2021 - 06/2005
7	Inflammation (Inflammations) 03/2016 - 02/2005
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 12/2006
5	Colitis 12/2014 - 06/2005
4	Pouchitis 03/2010 - 06/2005
3	Infections 01/2022 - 10/2012
3	Neoplasms (Cancer) 12/2020 - 02/2009
3	Body Weight (Weight, Body) 01/2019 - 10/2012
2	Melanoma (Melanoma, Malignant) 12/2020 - 02/2011
2	Skin Neoplasms (Skin Cancer) 12/2020 - 01/2019
2	Necrosis 07/2018 - 01/2017
2	Ulcer 03/2016 - 03/2010
1	Obesity 01/2022
1	Pancreatitis 01/2021
1	Hypoalbuminemia 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Heart Arrest (Cardiac Arrest) 12/2020
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	Hemorrhage 01/2019
1	Gaucher Disease (Gaucher's Disease) 01/2018
1	Tay-Sachs Disease 01/2018
1	Canavan Disease (Leukodystrophy, Spongiform) 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2016
1	Weight Loss (Weight Reduction) 03/2016
1	Fistula 03/2016
1	Diarrhea 03/2016
1	Back Pain (Backache) 10/2013
1	Ankylosing Spondylitis 10/2013
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2012
1	Chronic Granulomatous Disease 01/2011
1	Erythema 03/2010
1	Progressive Multifocal Leukoencephalopathy 11/2005
1	Hypersensitivity (Allergy) 09/2004

Drug/Important Bio-Agent (IBA)

6	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 10/2012
4	Interleukin-23 (Interleukin 23)IBA 01/2019 - 12/2006
4	AntibodiesIBA 10/2013 - 06/2005
4	AntigensIBA 01/2011 - 06/2005
3	Interleukin-12 (IL 12)IBA 01/2019 - 10/2012
3	Monoclonal AntibodiesIBA 11/2016 - 11/2007
3	SteroidsIBA 05/2012 - 11/2007
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2009 - 06/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 10/2012
2	Tumor Necrosis Factor InhibitorsIBA 11/2023 - 10/2012
2	Phenobarbital (Luminal)FDA Link 01/2022 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 11/2007
2	Infliximab (Remicade)FDA Link 01/2021 - 12/2014
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2011
2	FlagellinIBA 10/2013 - 02/2005
1	Ad26COVS1IBA 12/2021
1	mRNA VaccinesIBA 12/2021
1	Serum AlbuminIBA 01/2021
1	C 27 (C-27)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2016
1	Messenger RNA (mRNA)IBA 12/2014
1	Interleukin-17 (Interleukin 17)IBA 12/2012
1	Immunologic Factors (Immunomodulators)IBA 05/2012
1	IpilimumabIBA 02/2011
1	Protein Subunit VaccinesIBA 02/2011
1	Immunoglobulin A (IgA)IBA 01/2011
1	Capsules (Microcapsules)IBA 03/2010
1	Mesalamine (Mesalazine)FDA LinkGeneric 02/2009
1	visilizumabIBA 11/2007
1	CytokinesIBA 12/2006
1	Natalizumab (Tysabri)FDA Link 11/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2005
1	PorinsIBA 06/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2005
1	Immunoglobulins (Immunoglobulin)IBA 02/2005
1	Deoxyribonuclease I (Nickase)IBA 09/2004

Therapy/Procedure

11	Therapeutics 01/2022 - 11/2005
8	Restorative Proctocolectomy 01/2017 - 06/2005
2	Ileostomy 01/2017 - 03/2016
2	Colectomy 01/2010 - 02/2009
1	Contraindications 01/2013
1	Patient Readmission 05/2012
1	Chemoprevention 02/2009